Abstract
*Sanofi US, 1041 Route 202/206, Bridgewater, NJ 08807, USA E-mail: james.calkins@sanofi.com The America Invents Act (AIA) was signed into law by President Obama on 16 September 2011 [1]. The AIA changed more than a dozen aspects of US patent law and has a staged implementation. This article will summarize the AIA’s primary changes to US patent law and briefly describe a few potential implications of those changes, from the perspective of the pharmaceutical industry [1].
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
